Wirth Discusses SELECT Trial: Lenvatinib in RAI-Refractory DTC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Wirth Discusses SELECT Trial: Lenvatinib in RAI-Refractory DTC …
May 1, 2024
targetedonc.com
The Evolving Role of Lenvatinib in the HCC Therapeutic Landscape | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
The Evolving Role of Lenvatinib in the HCC Therapeutic Landscape | …
11 months ago
targetedonc.com
Gemcitabine-Oxaliplatin-Lenvatinib (GEMOX-LEN) For Unresectable Fibrolamellar Carcinoma: Promising Results in First 16 Patients
Gemcitabine-Oxaliplatin-Lenvatinib (GEMOX-LEN) For Unresectable Fi…
1 month ago
fibrofoundation.org
Dr. Feldman on Lenvatinib and Pembrolizumab Plus Chemotherapy in NSCLC | OncLive
Dr. Feldman on Lenvatinib and Pembrolizumab Plus Chemothera…
May 23, 2022
onclive.com
Frontline Lenvatinib in HCC: Study 304 | OncLive
Frontline Lenvatinib in HCC: Study 304 | OncLive
3 weeks ago
onclive.com
Study Results: Lenvatinib in Renal Cell Carcinoma | OncLive
Study Results: Lenvatinib in Renal Cell Carcinoma | OncLive
Jan 29, 2016
onclive.com
Lenvatinib/Pembrolizumab in RCC: Dosing and Adverse Event Management | OncLive
Lenvatinib/Pembrolizumab in RCC: Dosing and Adverse Event Manag…
Apr 1, 2022
onclive.com
Dr. Cheng on Phase III Findings of Lenvatinib in HCC | OncLive
Jun 26, 2017
onclive.com
Lenvatinib Pembrolizumab as Frontline Therapy for Advanced R…
Mar 7, 2022
onclive.com
Lenvatinib in Metastatic Renal Cell Carcinoma | OncLive
Dec 19, 2015
onclive.com
Metastatic CRC: Pembrolizumab Plus Lenvatinib | OncLive
Aug 17, 2021
onclive.com
Dr. Levy on Future Research Directions for Lenvatinib in HCC | …
Mar 4, 2021
onclive.com
Lenvatinib As Up-front Therapy for Unresectable HCC | OncLive
Nov 28, 2018
onclive.com
Dr. Finn on Considerations for Lenvatinib in Liver Cancer | OncLive
Sep 19, 2018
onclive.com
Dosing Lenvatinib for First-Line Renal Cell Carcinoma Treatment | …
Apr 19, 2022
cancernetwork.com
Primary Results from the Phase 3 Leap-002 Study: Lenvatinib plus P…
Sep 29, 2022
onclive.com
3:52
LEAP Study: Lenvatinib Plus Pembrolizumab in Patients With R…
Mar 8, 2024
onclive.com
Approval of Lenvatinib: More Options | OncLive
Mar 4, 2015
onclive.com
EMERALD-3: tremelimumab durvalumab with or without lenvat…
Sep 10, 2022
vjoncology.com
Endometrial Cancer: Toxicity Management and Treatment Persi…
3 months ago
onclive.com
Next Steps With Pembrolizumab/Lenvatinib in End…
Apr 15, 2024
onclive.com
Dr. Cabanillas on Lenvatinib as First-Line Therapy for Patients Wi…
Feb 20, 2016
onclive.com
Patient Profile 1: A 77-Year-Old Man with Advanced HCC Treated With …
Oct 14, 2022
onclive.com
Dr. Armaghany on Frontline Sorafenib Versus Lenvatinib in Un…
Apr 4, 2020
onclive.com
4:27
Lenvatinib in Renal Cell Carcinoma
626 viewsFeb 24, 2016
YouTubeOncLive
תופעות לוואי, אינטראקציות, שימושים והטבעה תרופתית של Lenvima (lenva…
Aug 24, 2019
oldmedic.com
1:46
Dr. Bible on Impact of Lenvatinib on Treatment Landscape of DTC
602 viewsFeb 19, 2016
YouTubeOncLive
KEYNOTE-775: Lenvatinib Plus Pembrolizumab in Advanced Endo…
Aug 3, 2023
onclive.com
0:05
Experiences and Thoughts on Lenvatinib for Cancer
7.6K views11 months ago
TikTokjasonkara
0:59
Dr. Martins on Managing Toxicities Associated With Lenvatinib in DTC
785 viewsFeb 25, 2016
YouTubeOncLive
See more videos
Static thumbnail place holder